Hemodynamic Disorders
Hemodynamic
Disorders
·
The health
of cells and tissues depends not only on an intact circulation to deliver
oxygen and remove wastes but also on normal fluid homeostasis.
·
Normal fluid
homeostasis requires vessel wall integrity as well as maintenance of intravascular
pressure and osmolarity within certain physiologic ranges.
·
Increases in
vascular volume or pressure, decreases in plasma protein content, or alterations
in endothelial function can result in a net outward movement of water across
the vascular wall.
·
Such water
extravasation into interstitial spaces is called edema; depending on its
location, edema may have minimal or profound effects.
·
Thus, in the
lower extremities edema fluid causes primarily swelling; however, in the lungs,
edema fluid will fill alveoli and can result in life-threatening breathing
difficulties.
·
Hemodynamic
Disorders…..
Normal fluid homeostasis also means maintaining
blood as a liquid until such time as injury necessitates formation of a clot.
Absence of clotting after vascular injury results in
hemorrhage; local bleeding can compromise regional tissue perfusion,
while more extensive hemorrhage can result in hypotension (shock) and
death.
Conversely, inappropriate clotting (thrombosis)
or migration of clots (embolism) can obstruct tissue blood supplies and
cause cell death (infarction).
Abnormal fluid homeostasis (i.e., hemorrhage or
thrombosis) underlies three of the most important causes of morbidity and
mortality in Western society: myocardial infarction, pulmonary embolism, and
cerebrovascular accident (stroke).
Hemodynamic Disorders
EDEMA
Approximately 60% of lean body weight is water, two-thirds
of which is intracellular and the remainder is in extracellular
compartments, mostly as interstitial fluid; only 5% of total body
water is in blood plasma.
The term edema signifies increased
fluid in the interstitial tissue spaces; fluid collections in
different body cavities are variously designated hydrothorax,
hydropericardium, or hydroperitoneum (the last is more commonly called
ascites).
Anasarca is a
severe and generalized edema with profound subcutaneous tissue swelling
The mechanism of inflammatory edema mostly involves
increased vascular permeability
Increased Hydrostatic Pressure
Impaired venous return
Congestive heart failure
Constrictive pericarditis
Ascites (liver cirrhosis)
Venous obstruction or compression
External pressure (e.g., mass)
Lower extremity inactivity with prolonged dependency
Arteriolar dilation
Heat
Neurohumoral dysregulation
Reduced Plasma Osmotic Pressure (Hypoproteinemia)
Protein-losing glomerulopathies (nephrotic syndrome)
Liver cirrhosis (ascites)
Malnutrition
Protein-losing gastroenteropathy
Lymphatic Obstruction
Inflammatory
Neoplastic
Postsurgical
Postirradiation
Sodium Retention
Excessive salt intake with renal insufficiency
Increased tubular reabsorption of sodium
Renal hypoperfusion
Increased renin-angiotensin-aldosterone secretion
Inflammation
Acute inflammation
Chronic inflammation
Angiogenesis
EDEMA
Clinical Correlation
The effects of edema may range from
merely annoying to rapidly fatal.
Subcutaneous edema in cardiac or renal failure is important primarily because it
indicates underlying disease; however, when significant it can
also impair wound healing or the clearance of infection.
In contrast, pulmonary edema can cause
death by interfering with normal ventilatory
function and also creates a favorable environment for bacterial infection.
Brain edema is
serious and can be rapidly fatal. If severe, brain edema can
cause herniation (extrusion of the brain) through the foramen
magnum; the brainstem vascular supply can also be compressed
by edema causing increased intracranial pressure. Either state can injure
the medullary centers and can cause death
HYPEREMIA AND CONGESTION
Both indicate a local increased volume of
blood in a particular tissue.
Hyperemia is an active process
resulting from augmented blood flow due to arteriolar
dilation (e.g., at sites of inflammation or in skeletal muscle during
exercise).
The affected tissue is redder than normal
because of engorgement with oxygenated blood.
Congestion is a passive process
resulting from impaired venous return out of a
tissue.
It may occur systemically, as in cardiac
failure, or it may be local, resulting from an isolated venous
obstruction.
The tissue has a blue-red color (cyanosis),
especially as worsening congestion leads to accumulation of deoxygenated
hemoglobin in the affected tissues
Chronic passive congestion
Congestion of
capillary beds is closely related to the development of edema,
so that congestion and edema commonly occur together.
In long-standing congestion, called chronic
passive congestion, the stasis of poorly oxygenated blood
causes chronic hypoxia, which in turn can result in degeneration
or death of parenchymal cells and subsequent tissue fibrosis.
Capillary rupture at such sites of chronic congestion can also cause small foci of
hemorrhage; phagocytosis and catabolism of the erythrocyte
debris can result in accumulations of hemosiderin-laden
macrophages.
Morphology
Cut surfaces of hyperemic or congested tissues are hemorrhagic
and wet.
Microscopically, acute pulmonary congestion is characterized by alveolar capillaries engorged with blood;
there may also be associated alveolar septal edema and/or focal minute
intra-alveolar hemorrhage.
In chronic pulmonary congestion the septa
become thickened and fibrotic, and the alveolar spaces may
contain numerous hemosiderin-laden macrophages ("heart failure
cells").
.
In acute hepatic congestion the central vein and sinusoids are distended with blood,
and there may even be central hepatocyte degeneration; the
periportal hepatocytes, better oxygenated because of their proximity to hepatic
arterioles, undergo less severe hypoxia and may develop only fatty change
In chronic passive congestion of the
liver the central regions of the hepatic lobules are grossly red-brown
and slightly depressed (because of a loss of cells) and are accentuated
against the surrounding zones of uncongested tan, sometimes fatty,
liver ("nutmeg liver").
Microscopically, there is centrilobular necrosis
with hepatocyte drop-out, hemorrhage, and hemosiderin-laden macrophages.
In long-standing, severe hepatic congestion (most
commonly associated with heart failure), hepatic fibrosis ("cardiac
cirrhosis") can develop.
It is important to note that because the central
portion of the hepatic lobule is the last to receive blood, centrilobular
necrosis can also occur whenever there is reduced hepatic blood flow (including
shock from any cause); there need not be previous hepatic congestion.
Liver with chronic passive congestion &
hemorrhagic necrosis.
HEMORRHAGE
Hemorrhage is extravasation of blood
from vessels into the extravascular space.
Capillary bleeding can occur under conditions of chronic congestion; an increased
tendency to hemorrhage (usually with insignificant injury) occurs in a
wide variety of clinical disorders collectively called hemorrhagic
diatheses.
Rupture of a large artery or vein results in severe hemorrhage, and is almost
always due to vascular injury, including trauma,
atherosclerosis, or inflammatory or neoplastic erosion of the vessel
wall.
Hemorrhage can be external or can be confined
within a tissue; any accumulation is referred to as a hematoma.
Hematomas can be relatively insignificant
(e.g., a bruise) or can involve so much bleeding as to cause
death (e.g., a massive retroperitoneal hematoma resulting from rupture
of a dissecting aortic aneurysm;
Types of Hemorrhage
Minute (1- to 2-mm) hemorrhages into skin,
mucous membranes, or serosal surfaces are called petechiae and are typically associated
with locally increased intravascular pressure, low platelet counts
(thrombocytopenia), defective platelet function, or clotting factor
deficiencies
Slightly larger (3- to 5-mm) hemorrhages are
called purpura and can be associated with many of the same disorders
that cause petechiae; in addition, purpura can occur with trauma,
vascular inflammation (vasculitis), or increased vascular fragility
Larger (1- to 2-cm) subcutaneous
hematomas (bruises) are called ecchymoses.
The erythrocytes in these local
hemorrhages are phagocytosed and degraded by macrophages; the hemoglobin
(red-blue color) is enzymatically converted into bilirubin
(blue-green color) and eventually into hemosiderin
(golden-brown), accounting for the characteristic color changes in a hematoma.
Large accumulations of blood in one or another of
the body cavities are called hemothorax, hemopericardium, hemoperitoneum, or
hemarthrosis (in joints).
Patients with extensive hemorrhages
occasionally develop jaundice from the massive breakdown of red
blood cells and systemic increases in bilirubin
Clinical Significance
Depends on the volume and rate of
blood loss.
Rapid removal
of around 20% of blood volume
or slow losses of even larger amounts may have little
impact in healthy adults;
Greater losses,
however, can cause hypovolemic shock.
The site of hemorrhage is also important; bleeding
that would be trivial in the subcutaneous tissues may cause death
if located in the brain.
Finally, chronic or recurrent external
blood loss (e.g., a peptic ulcer or menstrual bleeding) causes a net
loss of iron, leading to iron deficiency anemia.
In contrast, when red cells are retained
(e.g., with hemorrhage into body cavities or tissues), the iron can be
reutilized for hemoglobin synthesis.
A, Punctate petechial hemorrhages of the colonic
mucosa, a consequence of thrombocytopenia.
B, Fatal intracerebral hemorrhage.
B, Fatal intracerebral hemorrhage.
HEMOSTASIS AND THROMBOSIS
Normal hemostasis is a consequence
of tightly regulated processes that maintain blood in a fluid, clot-free
state in normal vessels while inducing the rapid formation of a
localized hemostatic plug at the site of vascular injury.
The pathologic form of hemostasis is thrombosis;
it involves blood clot (thrombus) formation in uninjured CVS or
thrombotic occlusion of a vessel after relatively minor injury.
Both
hemostasis and thrombosis involve three components: the vascular wall,
platelets, and the coagulation cascade.
Normal Hemostasis
Contribution of Endothelial Cells to Coagulation
Intact endothelial cells maintain liquid blood flow
by:
Actively inhibiting platelet adherence,
Preventing coagulation factor activation,
Lysing blood clots that may form.
Endothelial cells can be stimulated
by direct injury or by various cytokines that are produced during
inflammation.
Such stimulation results in expression of
procoagulant proteins (e.g., tissue factor and vWF) that
contribute to local thrombus formation.
Loss of endothelial integrity exposes underlying vWF
and basement membrane collagen, both substrates for platelet aggregation and
thrombus formation.
Platelet Aggregation
Endothelial injury exposes underlying basement
membrane ECM;
Platelets adhere to the ECM and become activated by binding to vWF
through GpIb platelet receptors.
Platelets secrete granule products that include calcium (activates coagulation proteins) and ADP
(mediates further platelet aggregation and degranulation).
Also synthesize TXA2 (increases
platelet activation and causes vasoconstriction).
Expose phospholipid complexes that provide an important surface for coagulation -protein
activation
Released ADP stimulates formation of a primary
hemostatic plug by activating platelet GpIIb-IIIa receptors that in turn
facilitate fibrinogen binding and cross-linking.
The formation of definitive secondary
hemostatic plug requires the activation of thrombin to cleave fibrinogen and form polymerized
fibrin via coagulation cascade
SUMMARY: Coagulation Factors
Coagulation occurs via the sequential enzymatic
conversion of a cascade of circulating and locally synthesized proteins.
Tissue factor
elaborated at sites of injury is the most important initiator of the
coagulation cascade; at the final stage of coagulation, thrombin converts fibrinogen into insoluble fibrin,
which helps to form the definitive hemostatic plug. Coagulation
is normally constrained to sites of vascular injury by:
Limiting enzymatic activation to phospholipid
complexes provided by activated platelets
Natural anticoagulants elaborated at sites of endothelial injury or during activation of the coagulation cascade
Induction of fibrinolytic pathways involving plasmin through the activities of various PAs
Thrombosis
There are three primary influences on thrombus
formation (called Virchow's triad):
(1) endothelial injury, (Alteration in wall)
(2) stasis or turbulence of blood flow
(Alteration in flow)
(3) blood hypercoagulability (Alteration in
cougulability)
Endothelial Injury
This is a dominant influence, since
endothelial loss by itself can lead to thrombosis.
It is particularly important for
thrombus formation occurring in the heart or in the arterial circulation,
where the normally high flow rates might otherwise hamper
clotting by preventing platelet adhesion or diluting
coagulation factors.
Thus, thrombus formation within the cardiac
chambers (e.g., after endocardial injury due to myocardial
infarction), over ulcerated plaques in atherosclerotic arteries,
or at sites of traumatic or inflammatory vascular injury (vasculitis)
is largely a function of endothelial injury.
Endothelial Injury….
Clearly, physical loss of endothelium
leads to exposure of subendothelial ECM, adhesion of platelets,
release of tissue factor, and local depletion of PGI2 and plasminogen
activators.
However, endothelium need not be denuded or
physically disrupted for thrombosis; any imbalance between prothrombotic
and antithrombotic activities of endothelium can influence local clotting
events
Significant endothelial dysfunction (in the absence
of endothelial cell loss) may occur with hypertension, turbulent flow over
scarred valves, or by the action of bacterial endotoxins.
Even relatively subtle influences, such as
homocystinuria, hypercholesterolemia, radiation, or products absorbed from
cigarette smoke, may be sources of endothelial dysfunction
Alterations in Normal Blood Flow
Turbulence contributes
to arterial and cardiac thrombosis by causing endothelial injury or
dysfunction, as well as by forming countercurrents and local
pockets of stasis; stasis is a major contributor to the
development of venous thrombi.
Normal blood flow is laminar, such that platelets flow centrally in
the vessel lumen, separated from the endothelium by a slower moving clear zone
of plasma. Stasis and turbulence therefore:
Disrupt laminar flow and bring platelets into
contact with the endothelium
Prevent dilution of activated clotting factors by fresh-flowing blood
Retard the inflow of clotting factor inhibitors and permit the buildup of thrombi
Promote endothelial cell activation, resulting in local thrombosis, leukocyte adhesion, etc.
Hypercoagulability
Generally contributes less frequently to
thrombotic .
It is loosely defined as any alteration of the
coagulation pathways that predisposes to thrombosis, and it can be
divided into primary (genetic) and secondary (acquired)
disorders .
Of the inherited causes mutations in the factor V
gene and the prothrombin gene are the most common:
Acquired thrombotic diatheses: multifactorial and complicated
In some situations (e.g., cardiac failure or
trauma), stasis or vascular injury may be most important.
Hypercoagulability due to use of oral
contraceptive use and hyperestrogenic state of pregnancy,
related to increased hepatic synthesis of coagulation factors and reduced
synthesis of antithrombin III.
In disseminated cancers, release of procoagulant
tumor products predisposes to thrombosis.
Hypercoagulability in advancing age has been
attributed to increasing platelet aggregation and reduced
endothelial PGI2 release.
Smoking and obesity promote hypercoagulability by unknown mechanisms
Hypercougulability
Morphology
Thrombi can develop anywhere in the
cardiovascular system (in cardiac chambers, on valves, in arteries, veins,
capillaries).
The size and shape of a thrombus depend
on the site of origin and the cause.
Arterial or cardiac thrombi begin at sites of endothelial injury or
turbulence; venous thrombi occur at sites of stasis.
Thrombi are focally attached to the
underlying vascular surface.
Arterial thrombi
tend to grow in a retrograde direction from the point of
attachment,
Venous thrombi
extend in the direction of blood flow (thus both tend to propagate
toward the heart).
The propagating portion of a thrombus
is poorly attached and therefore prone to fragmentation,
generating an embolus.
Morphology
Thrombi can have grossly (and microscopically)
apparent laminations called lines of Zahn; these represent
pale platelet and fibrin layers alternating with darker erythrocyte-rich
layers.
Such lines are
significant only in that they represent thrombosis in the setting
of flowing blood; their presence can therefore potentially distinguish
antemortem thrombosis from the bland nonlaminated postmortem
clots
Thrombi occurring in heart chambers or in the
aortic lumen are designated mural thrombi.
Morphology
Arterial thrombi are frequently occlusive and
are produced by platelet and coagulation activation; they are typically
a friable meshwork of platelets, fibrin, erythrocytes, and degenerating
leukocytes.
Venous thrombosis (phlebothrombosis) is almost
invariably occlusive, and the thrombus can create a long cast of the
lumen; venous thrombosis is largely the result of activation of the
coagulation cascade, and platelets play a secondary role.
Because these thrombi form in the sluggish venous
circulation, they also tend to contain more enmeshed erythrocytes and
are therefore called red, or stasis, thrombi.
Postmortem clots
Postmortem clots can sometimes be mistaken at
autopsy for venous thrombi.
Postmortem "thrombi"
are gelatinous, with a dark red dependent portion where
RBCs have settled by gravity, and a yellow "chicken fat"
supernatant, and they are usually not attached to the underlying
wall.
In contrast, red thrombi are firmer and
are focally attached, and sectioning reveals strands of gray fibrin.
Specific types of Thrombi
Thrombi on heart valves are called vegetations.
Bacterial or fungal blood-borne infections can cause
valve damage, subsequently leading to large thrombotic masses
(infective endocarditis,).
Sterile
vegetations can also develop on noninfected valves in hypercoagulable
states, so-called nonbacterial thrombotic endocarditis
Less commonly, sterile, verrucous endocarditis
(Libman-Sacks endocarditis) can occur in the setting of systemic lupus erythe
Fate of the Thrombus
Propagation:
accumulation of additional platelets and fibrin, eventually causing vessel
obstruction.
Embolization: Thrombi
dislodge or fragment and are transported elsewhere in the vasculature.
Dissolution: Thrombi
are removed by fibrinolytic activity.
Organization and recanalization.
Thrombi induce inflammation and fibrosis (organization).
These can eventually recanalize (re-establishing some
degree of flow), or they can be incorporated into a thickened vessel wall
Low-power view of an artery with an old thrombus.
A, H&E-stained section.
B, Stain for elastic tissue.
EMBOLISM
An embolus is a intravascular solid, liquid,
or gaseous mass that is carried by the blood to a site distant
from its point of origin (Formation or entry).
Virtually 99% of all emboli represent some
part of a dislodged thrombus, hence the term thromboembolism.
Rare forms of emboli include fat droplets,
bubbles of air or nitrogen, atherosclerotic debris (cholesterol
emboli), tumor fragments, bits of bone marrow, or foreign bodies such
as bullets.
EMBOLISM
However, unless otherwise specified,
an embolism should be considered to be thrombotic in origin.
Inevitably, emboli lodge in vessels too small
to permit further passage, resulting in partial or complete vascular
occlusion.
The consequences of thromboembolism
include ischemic necrosis (infarction) of downstream tissue.
Depending on the site of origin, emboli may lodge
anywhere in the vascular tree; the clinical outcomes are best understood from
the standpoint of whether emboli lodge in the pulmonary or
systemic circulations
Embolus derived from a lower extremity deep venous
thrombosis and now impacted in a pulmonary artery branch
Pulmonary Embolism
They are carried through progressively
larger channels and pass through the right side of the heart
before entering the pulmonary vasculature.
Depending on the size of the embolus, it may
occlude the main pulmonary artery, impact across bifurcation (saddle
embolus), or pass out into the smaller, branching
arterioles.
Frequently, there are multiple emboli,
perhaps sequentially, or as a shower of smaller emboli from a single
large thrombus; in general, the patient who has had one
pulmonary embolus is at high risk of having more.
Rarely, an embolus can pass through an interatrial
or interventricular defect, thereby entering the systemic
circulation (paradoxical embolism).
Pulmonary Embolism
Sudden death, right
ventricular failure (cor pulmonale), or cardiovascular collapse
occurs when 60% or more of the pulmonary circulation is obstructed with
emboli.
Embolic obstruction of medium-sized arteries can
cause pulmonary hemorrhage but usually not pulmonary infarction
because the lung has a dual blood supply and the intact bronchial
arterial circulation continues to supply blood to the area
Many emboli occurring over a period of time
may cause pulmonary hypertension with right ventricular failure.
Systemic Thromboembolism
Systemic
thromboembolism refers to emboli in the arterial circulation.
Most (80%) arise from intracardiac mural thrombi,
two-thirds of which are associated with left ventricular wall infarcts
and another quarter with dilated left atria (e.g., secondary to mitral
valve disease).
The remainder originate from aortic aneurysms,
thrombi on ulcerated atherosclerotic plaques, or fragmentation of valvular
vegetations
Arterial emboli can travel to a wide variety of
sites; the site of arrest depends on the point of origin
of the thromboembolus and the relative blood flow through the downstream tissues.
The major sites for
arteriolar embolization are the lower extremities (75%) and the brain
(10%), with the intestines, kidneys, and spleen affected
to a lesser extent
INFARCTION
An infarct is an area of ischemic necrosis
caused by occlusion of either the arterial supply or the venous drainage
in a particular tissue.
Tissue infarction is a common and extremely
important cause of clinical illness.
More than half of all deaths in the United States
are caused by cardiovascular disease, and most of these are attributable to myocardial
or cerebral infarction.
Pulmonary infarction is a common complication in
several clinical settings, bowel infarction is frequently fatal, and ischemic
necrosis of the extremities (gangrene) is a serious problem in the diabetic
population.
INFARCTION
Nearly 99% from thrombotic
or embolic events, and from arterial occlusion.
Infarction may also be caused by other
mechanisms:s local vasospasm, expansion of an atheroma
secondary to intraplaque hemorrhage, or extrinsic compression of a
vessel (e.g., by tumor).
Uncommon causes include vessel twisting
(e.g., in testicular torsion or bowel volvulus), vascular compression by edema
or entrapment in a hernia sac, or traumatic vessel rupture.
Although venous thrombosis can cause infarction, it
more often merely induces venous obstruction and congestion.
Usually, bypass channels open rapidly after
the occlusion forms, providing some outflow from the area that, in turn,
improves the arterial inflow.
Infarcts caused by venous thrombosis are more likely
in organs with a single venous outflow channel (e.g., testis and ovary).
Infarction…
Morphology
Infarcts are classified on the basis of their
color (reflecting the amount of hemorrhage) and the presence or
absence of microbial infection.
Therefore, infarcts may be either red
(hemorrhagic) or white (anemic) and may be either septic or bland.
Red infarcts occur;
(1) with venous occlusions (such as in
ovarian torsion);
(2) in loose tissues (lung) that allow blood
to collect in the infarcted zone;
(3) in tissues with dual circulations e.g.
lung and small intestine, permitting flow of blood from an unobstructed
parallel supply into a necrotic area
(4) in tissues that were previously congested
because of sluggish venous outflow;
(5) when flow is re-established to a site of
previous arterial occlusion and necrosis (e.g., fragmentation of an occlusive
embolus or angioplasty of a thrombotic lesion).
Infarction….Morphology
White infarcts occur with:
1. Arterial occlusions or in solid organs
(such as heart, spleen, and kidney), where the solidity of the tissue limits
the amount of hemorrhage that can seep into the area of ischemic necrosis from
adjoining capillary beds
All
infarcts tend to be wedge shaped, with the occluded vessel at the apex and the
periphery of the organ forming the base; when the base is a serosal surface
there can be an overlying fibrinous exudate.
At the
outset, all infarcts are poorly defined and slightly hemorrhagic. The margins
of both types of infarcts tend to become better defined with time by a narrow
rim of congestion attributable to inflammation at the edge of the lesion
Infarction…Morphology
The dominant histologic characteristic of infarction is ischemic coagulative necrosis.
An inflammatory response at the margins of
infarcts within a few hours and is usually well defined within 1 to 2 days.
Inflammatory response is followed by a
reparative response beginning in the preserved margins.
In stable or labile tissues, parenchymal
regeneration can occur at the periphery, where underlying stromal
architecture is spared.
However, most infarcts are ultimately replaced
by scar.
The brain is an exception to these generalizations;
ischemic tissue injury in the central nervous system results in liquefactive
necrosis .
Infarction….Morphology
Septic infarctions occur when bacterial
vegetations from a heart valve embolize or when microbes seed an area
of necrotic tissue.
In
these cases the infarct is converted into an abscess, with a correspondingly
greater inflammatory response.
The
eventual sequence of organization, however, follows the pattern previously
described.
Factors That Influence Development of an Infarct
Vascular occlusion can have no or minimal
effect, or can cause death of a tissue or even the individual.
The major determinants of the eventual outcome
include the;
nature of the vascular supply,
the rate of development of the occlusion,
vulnerability to hypoxia,
and the oxygen content of blood.
Red and white infarcts. A, Hemorrhagic, roughly wedge-shaped
pulmonary infarct (red infarct). B, Sharply demarcated pale infarct in
the spleen (white infarct).
Kidney infarct, now replaced by a large fibrotic
scar.
SHOCK
Shock is the final common pathway for
a number of potentially lethal clinical events, including severe
hemorrhage, extensive trauma or burns, large myocardial infarction, massive
pulmonary embolism, and microbial sepsis.
Regardless of the underlying pathology, shock
gives rise to systemic hypoperfusion; it can be caused either by reduced
cardiac output or by reduced effective circulating blood volume.
The end results are hypotension, impaired
tissue perfusion, and cellular hypoxia.
Although the hypoxic and metabolic effects of
hypoperfusion initially cause only reversible cellular injury,
persistence of shock eventually causes irreversible tissue injury
and can culminate in the death of the patient.
Types of Shock
Other types of Shock
Less commonly, shock may occur in the setting of an
anesthetic accident or a spinal cord injury (neurogenic shock),
as a result of loss of vascular tone and peripheral pooling of blood.
Anaphylactic shock represents systemic vasodilation and increased vascular
permeability caused by an immunoglobulin E hypersensitivity reaction.
In these situations, acute severe widespread vasodilation results in tissue
hypoperfusion and cellular anoxia.
Cardiogenic shock
Results from failure of the cardiac pump:
Myocardial damage (infarction),
Ventricular arrhythmias,
extrinsic compression (cardiac tamponade,),
or outflow obstruction (e.g., pulmonary embolism).Hypovolemic
shock results from loss of blood or plasma volume. This may be caused by
hemorrhage, fluid loss from severe burns, or trauma.
Septic shock
Is caused by microbial infection.
Most commonly this occurs in the setting of gram-negative
infections (endotoxic shock), but it can also occur with
gram-positive and fungal infections.
Notably, there need not be systemic bacteremia
to induce septic shock; host inflammatory responses to local extravascular
infections may be sufficient.
Comments
Post a Comment